Please login to the form below
Elan
This page shows the latest Elan news and features for those working in and with pharma, biotech and healthcare.
Teva planning fresh offer for Mylan, say sources
Perrigo meanwhile is in the midst of its own buying spree having bought Belgium's Omega Pharma last November and Elan in 2013 and has just been linked to a possible
Latest news
-
Perrigo buys consumer health products from GSK
Perrigo completed a 3.6bn takeover of Belgian consumer health firm Omega Pharma last November - having already bought Elan for $8.6bn in 2013 to allow it to cut its tax
-
Transition takes on Lilly muscle-boosting drug
It was previously licensed to Elan but was handed back after Elan was taken over by Perrigo.
-
Mylan swoops in on Perrigo with $30bn offer
Perrigo has itself made some significant acquisitions over the past two years, buying OTC drugmaker Omega for $5.3bn last year, a year after paying $8.6bn for Elan, which focuses
-
Daiichi Sankyo pays $39m in whistleblower case
Prior federal actions on alleged inducements for promoting or prescribing medicines in the last few years have involved Novartis, Amgen, Johnson &Johnson, Elan, Eisai, Abbott and Boehringer Ingelheim, amongst others.
-
Perrigo expands consumer health with €3.6bn Omega purchase
Follows takeover of Elan last year. Perrigo's range of consumer products. ... It follows Perrigo's acquisition last year of Elan for $8.6bn, which allowed the company to move its base from the US to Ireland, reducing its corporate tax and expanding
More from news
Approximately 11 fully matching, plus 104 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2017
The largest of these was Perrigo's divestment to Royalty Pharma of its royalty stream from Biogen's global sales of Tysabri (natalizumab), the multiple sclerosis antibody originally developed by Elan,
-
Pharma deals during November 2014
This follows Perrigo's acquisition of Elan in July last year for $8.6bn.
-
Pharma deals during September 2014
2011. Alkermes. Elan. Ireland. 2012. Jazz. Azur. Ireland. 2013. Liberty Global. ... Virgin Media. UK. 2013. Actavis. Warner Chilcott. Ireland. 2013. Perrigo. Elan.
-
Pharma deals during July 2014
In the last three days of July 2013, nine deals were announced with a total value of just over $12bn, of which Irish-based Elan's $8.6bn acquisition by Perrigo ... This time it is AbbVie's acquisition of Shire, albeit for a much bigger price tag than Elan
-
Pharma deals during March 2014
This follows on from several other acquisitions of Irish entities, which result in US companies paying Irish corporation tax, eg the acquisition by Perrigo of Elan and Actavis' acquisition of Warner
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
EMD Serono president James Hoyes joins consultants RxC
Prior to joining EMD Serono, Hoyes held leadership positions with the likes of Serono, Elan and Sanofi.
-
Turing names Eliseo Salinas as head of R&D
Prior to that, Salinas held multiple senior medical and science positions at biopharma companies including Elan Pharmaceuticals, Adolor and Shire, where he served as chief scientific officer.
-
Teva appoints Timothy Wright as business development head
Before that he was CEO (Interim) and Presidentat AAI Pharmaceuticals/Xanodyne and held various roles at Elan Pharmaceuticals and DuPont Merck Pharmaceutical Company.
-
Michael Fleming joins biosimilars firm Coherus
He has experience at Elan, Genentech and GSK. Coherus Biosciences has named Michael Fleming as senior VP, commercial strategy. ... Fleming was most recently at Elan where he was head of commercial and of the company's Tysabri (natalizumab) franchise.
-
Synergy Vision expands UK and Ireland team
In addition to her time at Pfizer, Hurley has experience as sales director at Nightline Logistics Group, field sales manager at Elan and medical communications director at L'Oreal.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting
Advisers involved in this transaction included:. KPMG Manchester acted on behalf of Fishawack Health for financial and tax due diligence; Craig Scott and Elan Iorwerth, Hill Dickinson (Liverpool), together with Jamie
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Sanofi Global Health unveils new nonprofit Impact brand
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- My journey advancing the science in pulmonary hypertension
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- The Power of AI in Medical Education
- First evidence-based guide launched to put patients at heart of digital innovations
- FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease
- New Swiss research reveals how Omicron evades the immune system
- Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021
- Michael Grela Elected President of the Society for Health Communication
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- A creative awakening – how pharma is bringing innovation to the patient journey
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Pfizer/BioNTech, AZ vaccines effective against Delta COVID-19 variant after two doses
- Shionogi Europe and NHS England agree on antibiotic subscription model
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Five big changes in the healthcare comms landscape
- The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- What communications are required for a successful launch...
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
